Publication | Closed Access

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Treatment And PreventionMedicineHuman RetrovirusClinical TrialsRilpivirine Versus EfavirenzAntiviral TherapyPharmacotherapyNon-inferiority TrialTreatment-naive AdultsAntiviral DrugHivPharmacology